Latest Car T News

Locality Planning Energy has signed a 15-year energy services agreement with Walker Corporation for its SOL development in Maroochydore. The contract expands LPE’s property developer network, but revenue and infrastructure costs remain undisclosed and will build progressively from late 2027.

PWR Holdings has lifted its FY27 Aerospace and Defence revenue growth outlook to around 50% after delivering record FY26 revenue of $170.7 million. A new US$4.6 million pre-contract order and a planned Polish manufacturing site are adding momentum, although the larger defence opportunity remains subject to customer and program decisions.

MONEYME opened FY27 with stronger growth, record-low net credit losses and its third consecutive quarter of positive Normalised NPAT. The unaudited result supports the lender’s reaffirmed FY27 target of breakeven to $7 million, while its expanding unsecured portfolio remains an important test.

AdAlta expects an additional R&D Tax Incentive refund of more than A$1 million after securing approval for specified overseas work on its EW-001 CAR-T therapy. The cash benefit arrives as the company prepares for a US FDA pre-IND meeting in November.

Monadelphous Group Limited (ASX:MND) enters FY27 with record FY26 revenue of $2.98 billion, a 52.1% profit increase and more than $680 million of new contracts secured since year-end. The engineering services group is also carrying a disputed claim worth about $200 million and a sizeable exposure to fossil-fuel markets.

Pengana Private Equity Trust will target cash distributions of at least 6% a year as portfolio realisations accelerate, led by progressive sales of SpaceX. The trust will also abandon its formulaic buyback allocation framework in favour of a more opportunistic approach.

Carma delivered a much larger operation in FY26, with revenue up 59% and gross profit doubling, but the online used-car retailer remains deeply loss-making. Its next test is converting new sourcing and reconditioning capacity into faster inventory turnover and lower cash burn.

Sena & Co has secured 98.796% of 2 Cheap Cars after its $0.90-per-share takeover offer closed, triggering compulsory acquisition of the remaining shares. Trading is due to end on NZX next week, with delisting expected on 21 October.

Arovella Therapeutics has released a second clinical batch of its off-the-shelf CAR-iNKT therapy ALA-101, with material expected to support dose escalation and the start of dose expansion in blood cancers. The company is also adding hospital sites ahead of anticipated first-patient dosing in late October.

Connexion Mobility has secured an exclusive supplier agreement with Hyundai Motor America to design, develop and manage a connected car-powered dealer lot platform across the United States. The strategic win adds a major OEM relationship, but its financial value and dealer uptake remain undisclosed.

AdAlta and Shanghai Cell Therapy Group have approved the FDA briefing pack and manufacturing transfer plan for EW-001, bringing the mesothelioma CAR-T therapy closer to an Australian Phase 1 trial. The FDA meeting is scheduled for November, while two Chinese patients remain under follow-up, including a second complete responder.

Ampol will acquire Evie Networks for $225 million in a debt-funded deal that would more than triple its public charging footprint to approximately 1,425 bays. The transaction offers a faster route into Australia’s expanding EV infrastructure market, but its earnings case depends on regulatory clearance, integration and rising utilisation.